Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Probucol prevents blood-brain barrier dysfunction in wild-type mice induced by saturated fat or cholesterol feeding.

Takechi R, Galloway S, Pallebage-Gamarallage MM, Lam V, Dhaliwal SS, Mamo JC.

Clin Exp Pharmacol Physiol. 2013 Jan;40(1):45-52. doi: 10.1111/1440-1681.12032.

PMID:
23167559
2.

Post-prandial lipid metabolism, lipid-modulating agents and cerebrovascular integrity: implications for dementia risk.

Pallebage-Gamarallage MM, Takechi R, Lam V, Galloway S, Dhaliwal S, Mamo JC.

Atheroscler Suppl. 2010 Jun;11(1):49-54. doi: 10.1016/j.atherosclerosissup.2010.04.002. Epub 2010 Apr 28. Review.

PMID:
20430703
3.

Restoration of dietary-fat induced blood-brain barrier dysfunction by anti-inflammatory lipid-modulating agents.

Pallebage-Gamarallage M, Lam V, Takechi R, Galloway S, Clark K, Mamo J.

Lipids Health Dis. 2012 Sep 17;11:117. doi: 10.1186/1476-511X-11-117.

4.

Nicotine Attenuates Disruption of Blood-Brain Barrier Induced by Saturated-Fat Feeding in Wild-Type Mice.

Elahy M, Lam V, Pallebage-Gamarallage MM, Giles C, Mamo JC, Takechi R.

Nicotine Tob Res. 2015 Dec;17(12):1436-41. doi: 10.1093/ntr/ntv044. Epub 2015 Mar 5.

PMID:
25744960
5.

Dietary fats, cerebrovasculature integrity and Alzheimer's disease risk.

Takechi R, Galloway S, Pallebage-Gamarallage MM, Lam V, Mamo JC.

Prog Lipid Res. 2010 Apr;49(2):159-70. doi: 10.1016/j.plipres.2009.10.004. Epub 2009 Nov 5. Review.

PMID:
19896503
6.

Probucol suppresses enterocytic accumulation of amyloid-β induced by saturated fat and cholesterol feeding.

Pallebage-Gamarallage MM, Galloway S, Takechi R, Dhaliwal S, Mamo JC.

Lipids. 2012 Jan;47(1):27-34. doi: 10.1007/s11745-011-3595-4. Epub 2011 Jul 31.

PMID:
21805327
7.

Aging-related changes in blood-brain barrier integrity and the effect of dietary fat.

Takechi R, Pallebage-Gamarallage MM, Lam V, Giles C, Mamo JC.

Neurodegener Dis. 2013;12(3):125-35. doi: 10.1159/000343211. Epub 2012 Nov 2.

PMID:
23128303
8.

Nutraceutical agents with anti-inflammatory properties prevent dietary saturated-fat induced disturbances in blood-brain barrier function in wild-type mice.

Takechi R, Pallebage-Gamarallage MM, Lam V, Giles C, Mamo JC.

J Neuroinflammation. 2013 Jun 19;10:73. doi: 10.1186/1742-2094-10-73.

9.

Differential effects of dietary fatty acids on the cerebral distribution of plasma-derived apo B lipoproteins with amyloid-beta.

Takechi R, Galloway S, Pallebage-Gamarallage MM, Wellington CL, Johnsen RD, Dhaliwal SS, Mamo JC.

Br J Nutr. 2010 Mar;103(5):652-62. doi: 10.1017/S0007114509992194. Epub 2009 Oct 28.

PMID:
19860996
10.

Long-term probucol therapy continues to suppress markers of neurovascular inflammation in a dietary induced model of cerebral capillary dysfunction.

Takechi R, Pallebage-Gamarallage MM, Lam V, Giles C, Mamo JC.

Lipids Health Dis. 2014 Jun 3;13:91. doi: 10.1186/1476-511X-13-91.

11.

The effect of exogenous cholesterol and lipid-modulating agents on enterocytic amyloid-beta abundance.

Pallebage-Gamarallage MM, Galloway S, Johnsen R, Jian L, Dhaliwal S, Mamo JC.

Br J Nutr. 2009 Feb;101(3):340-7. doi: 10.1017/S0007114508012269. Epub 2008 Jul 17.

PMID:
18631412
12.
13.

A diet enriched in docosahexanoic Acid exacerbates brain parenchymal extravasation of apo B lipoproteins induced by chronic ingestion of saturated fats.

Pallebage-Gamarallage MM, Lam V, Takechi R, Galloway S, Mamo JC.

Int J Vasc Med. 2012;2012:647689. doi: 10.1155/2012/647689. Epub 2011 Nov 10.

14.

Pharmacological modulation of dietary lipid-induced cerebral capillary dysfunction: Considerations for reducing risk for Alzheimer's disease.

Pallebage-Gamarallage M, Takechi R, Lam V, Elahy M, Mamo J.

Crit Rev Clin Lab Sci. 2016;53(3):166-83. doi: 10.3109/10408363.2015.1115820. Epub 2015 Dec 18. Review.

PMID:
26678521
15.

High-Density Lipoprotein Proteomic Composition, and not Efflux Capacity, Reflects Differential Modulation of Reverse Cholesterol Transport by Saturated and Monounsaturated Fat Diets.

O'Reilly M, Dillon E, Guo W, Finucane O, McMorrow A, Murphy A, Lyons C, Jones D, Ryan M, Gibney M, Gibney E, Brennan L, de la Llera Moya M, Reilly MP, Roche HM, McGillicuddy FC.

Circulation. 2016 May 10;133(19):1838-50. doi: 10.1161/CIRCULATIONAHA.115.020278. Epub 2016 Apr 14.

16.

Synergistic effects of high fat feeding and apolipoprotein E deletion on enterocytic amyloid-beta abundance.

Galloway S, Pallebage-Gamarallage MM, Takechi R, Jian L, Johnsen RD, Dhaliwal SS, Mamo JC.

Lipids Health Dis. 2008 Apr 22;7:15. doi: 10.1186/1476-511X-7-15.

17.
18.

Probucol, a lipid-lowering drug, prevents cognitive and hippocampal synaptic impairments induced by amyloid β peptide in mice.

Santos DB, Peres KC, Ribeiro RP, Colle D, dos Santos AA, Moreira EL, Souza DO, Figueiredo CP, Farina M.

Exp Neurol. 2012 Feb;233(2):767-75. doi: 10.1016/j.expneurol.2011.11.036. Epub 2011 Dec 8.

19.

Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects: the DELTA Study, protocol 1.

Ginsberg HN, Kris-Etherton P, Dennis B, Elmer PJ, Ershow A, Lefevre M, Pearson T, Roheim P, Ramakrishnan R, Reed R, Stewart K, Stewart P, Phillips K, Anderson N.

Arterioscler Thromb Vasc Biol. 1998 Mar;18(3):441-9.

Supplemental Content

Support Center